Amid one of the worst flu seasons the U.S. has seen in years, the Food and Drug Administration has canceled a key meeting to discuss next year’s vaccine.
The annual meeting of the administration’s Vaccines and Related Biological Products Advisory Committee had been scheduled for March 13. That meeting is now off the schedule. The meeting allowed experts to discuss the upcoming season and determine which strains to include in the upcoming vaccine.